These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39117067)

  • 21. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
    Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
    PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression.
    Luo Y; Huang K; Zheng J; Zhang J; Zhang L
    Gene; 2019 Mar; 688():19-25. PubMed ID: 30447345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
    Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
    Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma.
    Zhang M; Sui C; Dai B; Shen W; Lu J; Yang J
    Oncol Rep; 2017 Jan; 37(1):510-518. PubMed ID: 28004118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways.
    Chen X; Yan N
    Anticancer Drugs; 2021 Sep; 32(8):786-792. PubMed ID: 33675608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
    Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop.
    Zeng Y; Yao X; Chen L; Yan Z; Liu J; Zhang Y; Feng T; Wu J; Liu X
    Oncotarget; 2016 Sep; 7(39):63324-63337. PubMed ID: 27556509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
    Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy induces transforming growth factor-β-dependent epithelial-mesenchymal transition in hepatocarcinoma cells through cAMP response element binding signalling.
    Hu S; Wang L; Zhang X; Wu Y; Yang J; Li J
    J Cell Mol Med; 2018 Nov; 22(11):5518-5532. PubMed ID: 30134011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK/mTOR dependent autophagy activation.
    Gao L; Lv G; Li R; Liu WT; Zong C; Ye F; Li XY; Yang X; Jiang JH; Hou XJ; Jing YY; Han ZP; Wei LX
    Cancer Lett; 2019 Jul; 454():215-223. PubMed ID: 30980867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18[Formula: see text]-Glycyrrhetinic Acid Inhibits TGF-[Formula: see text]-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Targeting STAT3.
    Jie M; Zhang ZQ; Deng N; Liu QM; Wang C; Ge QY; Du PC; Song SS; Zhang XW; Long-Xin ; Liang HF; Chu L; Zhang L; Chen XP; Chen J; Dong HH; Zhang BX
    Am J Chin Med; 2022; 50(1):313-332. PubMed ID: 34963428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation.
    Tong H; Yin H; Hossain MA; Wang Y; Wu F; Dong X; Gao S; Zhan K; He W
    J Cell Biochem; 2019 Apr; 120(4):5118-5127. PubMed ID: 30320898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.